As of 2024-09-11, the Relative Valuation of Bio Rad Laboratories Inc (BIO) is (1,473.24) USD. This relative valuation is based on P/E multiples. With the latest stock price at 324.21 USD, the upside of Bio Rad Laboratories Inc based on Relative Valuation is -554.4%.
The range of the Relative Valuation is (1,352.67) - (1,612.36) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 27.7x - 34.7x | 30.4x |
| Forward P/E multiples | 28.4x - 33.9x | 31.6x |
| Fair Price | (1,352.67) - (1,612.36) | (1,473.24) |
| Upside | -517.2% - -597.3% | -554.4% |
| Date | P/E |
| 2024-09-10 | -6.82 |
| 2024-09-09 | -6.79 |
| 2024-09-06 | -6.93 |
| 2024-09-05 | -7.01 |
| 2024-09-04 | -6.96 |
| 2024-09-03 | -7.03 |
| 2024-08-30 | -7.09 |
| 2024-08-29 | -7.02 |
| 2024-08-28 | -6.91 |
| 2024-08-27 | -6.71 |
| 2024-08-26 | -6.59 |
| 2024-08-23 | -6.62 |
| 2024-08-22 | -6.52 |
| 2024-08-21 | -6.65 |
| 2024-08-20 | -6.70 |
| 2024-08-19 | -6.86 |
| 2024-08-16 | -6.85 |
| 2024-08-15 | -6.85 |
| 2024-08-14 | -6.74 |
| 2024-08-13 | -6.85 |
| 2024-08-12 | -6.69 |
| 2024-08-09 | -6.84 |
| 2024-08-08 | -6.90 |
| 2024-08-07 | -6.70 |
| 2024-08-06 | -6.87 |
| 2024-08-05 | -6.91 |
| 2024-08-02 | -7.06 |
| 2024-08-01 | -7.17 |
| 2024-07-31 | -7.11 |
| 2024-07-30 | -7.15 |
| 2024-07-29 | -6.85 |
| 2024-07-26 | -6.72 |
| 2024-07-25 | -6.63 |
| 2024-07-24 | -6.52 |
| 2024-07-23 | -6.42 |
| 2024-07-22 | -6.35 |
| 2024-07-19 | -6.24 |
| 2024-07-18 | -6.31 |
| 2024-07-17 | -6.70 |
| 2024-07-16 | -6.61 |
| 2024-07-15 | -6.35 |
| 2024-07-12 | -6.39 |
| 2024-07-11 | -6.21 |
| 2024-07-10 | -5.89 |
| 2024-07-09 | -5.78 |
| 2024-07-08 | -5.78 |
| 2024-07-05 | -5.82 |
| 2024-07-03 | -5.68 |
| 2024-07-02 | -5.63 |
| 2024-07-01 | -5.55 |